D.C. Law 22-128. Medical Marijuana Certified Business Enterprise Preference Amendment Act of 2018.
To amend the Legalization of Marijuana for Medical Treatment Initiative of 1999 to establish a preference for certified business enterprises that apply for the registration of a dispensary, cultivation center, or testing laboratory.
BE IT ENACTED BY THE COUNCIL OF THE DISTRICT OF COLUMBIA, That this act may be cited as the "Medical Marijuana Certified Business Enterprise Preference Amendment Act of 2018".
Sec. 2. Section 7(d) of the Legalization of Marijuana for Medical Treatment Initiative of 1999, effective July 27, 2010 (D.C. Law 18-210; D.C. Official Code § 7-1671.06(d)), is amended by adding a new paragraph (5) to read as follows:
"(5)(A) Any application for registration of a dispensary, cultivation center, or testing laboratory submitted by a certified business enterprise pursuant to this subsection after the effective date of the Medical Marijuana Certified Business Enterprise Preference Emergency Amendment Act of 2017, effective June 28, 2017 (D.C. Act 22-83; 64 DCR 6229), shall be awarded a preference equal to 20 points or 7.5% of the available points, whichever is more.
"(B) For the purposes of this paragraph, the term "certified business enterprise" shall have the same meaning as provided in
Sec. 3. Fiscal impact statement.
The Council adopts the fiscal impact statement in the committee report as the fiscal impact statement required by section 4a of the General Legislative Procedures Act of 1975, approved October 16, 2006 (120 Stat. 2038; D.C. Official Code § 1-301.47a).
Sec. 4. Effective date.
The act shall take effect following approval by the Mayor (or in the event of veto by the Mayor, action by the Council to override the veto), a 30-day period of congressional review as provided in section 602(c)(1) of the District of Columbia Home Rule Act, approved December 24, 1973, (87 Stat. 813; D.C. Official Code § 1-206.02(c)(1)), and publication in the District of Columbia Register.